Medizone International Inc. (OTCBB: MZEI) Recent Amazing Press Release Covers a Lot of Ground
STOCKGURU PROFILE FOR MEDIZONE - CORPORATE WEB SITE
Medizone International Inc. (OTCBB: MZEI) Recent Amazing Press Release Covers a Lot of Ground
Okay, you just have got to love that MEDIZONE INTERNATIONAL, INC.
These guys are the kings of understatement. I never get tired of covering them. The last sentence of the incredible press release recently:
The target is to achieve profitability moving into mid-year 2010.
Oh, and by the way … they are moving at light speed. They have gotten their documentation ready to list the company on the Over The Counter Bulletin Board (OTCBB) sooner that you may realize. REMEMBER, THEY HAVE BEEN ON THE BULLETIN BOARD IN THE PAST- AND HAVE ALWAYS BEEN FULLY REPORTING.
They will hospital testing during October. As in HOSPITALS where the serious sales will be. As in hospitals where the serious infections are. As in hospitalss where BOTH State Legislatures and the U.S. Congress are demanding a stop to the spread of nosocomial infections. As in — yeah … I bet they expect to achieve profitability in mid year 2010.
They are in the absolute cat bird seat with a product desperately needed in our broken down healthcare system.
When you have a product for which there is a pent-up demand you have shareholder value.
The company has a commercial viable plan for a product that is being demanded by the United States Congress — FINALLY.
Contact:
Medizone International, Inc. (OTC: MZEI)
144 Buena Vista
P.O. Box 742
Stinson Beach, CA 94970
Web: http://www.medizoneint.com
Telephone: 415-868-0300
Fax: 415-868-2344
Investor Relations 800-953-3350
E-mail: operations@medizoneint.com
This blog contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact in this announcement are forward-looking statements, including but not limited to,the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.
